- Review
The Role of microRNAs as Potential Biomarkers in Diffuse Large B-Cell Lymphoma
- Eirini Panteli,
- Epameinondas Koumpis,
- Vasileios Georgoulis,
- Georgios Petros Barakos,
- Evangelos Kolettas,
- Panagiotis Kanavaros,
- Alexandra Papoudou-Bai and
- Eleftheria Hatzimichael
Diffuse large B-cell lymphoma (DLBCL) is the most common and clinically aggressive subtype of non-Hodgkin lymphoma (NHL). While novel therapies such as rituximab and polatuzumab vedotin have led to improved outcomes, approximately 35% of patients eve...

